Barclays
RNLX

Barclays’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Barclays’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-67,948
Closed -$166K – 5210
2022
Q2 		$166K Hold
67,948
– – ﹤0.01% 3541
2022
Q1 		$470K Buy
+67,948
New +$720K ﹤0.01% 2953

Other funds holding RNLX

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Barclays's RNLX Position: Q3 2022 in Review

Barclays sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2022, closing a stake of 67,948 shares — an estimated $166K sold.

Barclays first reported a position in RNLX in Q1 2022 and held it in 2 quarters. The position peaked at $470K in Q1 2022. 27 funds tracked by Wall St. Rank hold RNLX as of Q3 2022.

  • Barclays reported no remaining Renalytix plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 67,948 Renalytix plc American Depositary Shares shares in Q3 2022, an estimated $166K.
  • Barclays first reported a position in Renalytix plc American Depositary Shares in Q1 2022 and held it in 2 quarters.
  • Barclays's Renalytix plc American Depositary Shares position peaked at $470K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.